Submit RFI/RFP
Category

news2

Indrė Dryžienė MBI, MM

The CIS Region: Excellent Potential for Patient Recruitment but is there any Risk to Quality?

By | news2

The number of clinical trials worldwide is increasing more than 10% each year due to the new diseases, further research for better health products and development of new drugs. Though, for a successful clinical trial, there is a major challenge – patient recruitment, which is essential and the most challenging factor due to the increasing number of new clinical trials. In order to achieve the required patient recruitment, sponsors are looking for different solutions.

Read More
Gediminas Zvicevičius MPharm, Lead Pharmacovigilance Specialist at Biomapas .

The Predicted Impact of the ISO IDMP Standards Implementation Process Carried Out by the European Medicines Agency

By | news2

The IDMP is a general term by which the 5 ISO data standards are referenced: ISO 11615 (regulated medicinal product information), ISO 11616 (regulated pharmaceutical product information), ISO 11238 (substances), ISO 11239 (pharmaceutical dose forms, units of presentation, routes of administration and packaging) and ISO 11240 (units of measurement). – which are being refined and implemented by regulatory bodies.

Read More
Monika Staniulytė, MPharm

Falsified Medicines Directive Implementation – Marketing Authorization Holder Perspective

By | news2

Falsified Medicines Directive (FMD) 2011/62/EU which aims to increase the security of manufacturing and delivery of medicines across Europe as well as protect patients and prevent falsified medicines from entering the supply chain has come in force Feb 9th, 2019. With the first quarter almost over, it is a great opportunity to look back and share the experience. The new requirements for safety features to appear on the packaging of all prescription medicines.

Read More